Pelthos Therapeutics Inc. (PTHS)

NYSEAMERICAN: PTHS · Real-Time Price · USD
22.00
+0.13 (0.59%)
At close: Jul 24, 2025, 4:00 PM
22.00
0.00 (0.00%)
After-hours: Jul 24, 2025, 8:00 PM EDT
0.59%
Market Cap14.51M
Revenue (ttm)n/a
Net Income (ttm)-7.36M
Shares Out 659.59K
EPS (ttm)-12.40
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume6,769
Open21.82
Previous Close21.87
Day's Range20.43 - 22.20
52-Week Range4.50 - 54.29
Betan/a
Analystsn/a
Price Targetn/a
Earnings DateAug 12, 2025

About PTHS

Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens. The company offers ZELSUVMI for the treatment of molluscum contagiosum in adults and children 1 year of age and older. It also provides NITRICIL, a proprietary nitric oxide-based technology platform. The company was formerly known as Channel Therapeutics Corporation and changed its name to Pelthos Therapeutics Inc. in July 2025. Pelthos Therapeutics Inc. was founded in 2002 and is based in Durh... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Employees 11
Stock Exchange NYSEAMERICAN
Ticker Symbol PTHS
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.